Luxembourg Cohort of Positive Patients for COVID-19: A Stratification Study to Predict Patient Prognosis 2020-2024, Month 12, 15 and 24 Long COVID Symptoms Aggregated Dataset
General Info
Original or alternative title
Predi-COVID; M12, M15, and M24
Coverage type
Country
Time period covered
May, 2020 - July, 2024
Data type
Survey:
Individual - Longitudinal
Summary
"The “Predi-COVID” cohort study aims to identify important risk factors and biomarkers associated with COVID-19 severity, long-term health consequences of the disease and viral escaping natural or induced COVID-19 immunity. The main objective of Predi-COVID is to identify clinical, epidemiological and omics characteristics associated with the severity of COVID-19, which will then be used to further stratify the study population into clusters of disease severity with similar pattern and disease course. The Predi-COVID study was approved by the Luxembourgish Ministry of Health and by the National Committee for Research Ethic on April 23rd, 2020 and has been registered on Clinicaltrials.gov (NCT04380987)"
Source: Predi-COVID
Citation
Contributors
Funders
Publisher
Publication year
2024
Suggested citation
Hospital Center of Luxembourg, Luxembourg Institute of Health (LIH), National Laboratory of Health (Luxembourg), Robert Schuman Hospital (Luxembourg). Luxembourg Cohort of Positive Patients for COVID-19: A Stratification Study to Predict Patient Prognosis 2020-2024, Month 12, 15 and 24 Long COVID Symptoms Aggregated Dataset. Luxembourg: Luxembourg Institute of Health (LIH), 2024.